John S. Yu

CEO

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 1 buy · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€5,430

▼ Sales (0 ops.)

—

Latest filing published 26 Nov 2025 for Kairos Pharma, LTD.. Read the official filing

Filing timeline

BuySale

John S. Yu

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Kairos Pharma, LTD. 1 purchase · last 21 Nov 2024

John S. Yu: trading record in brief

All filings by John S. Yu on record concern Kairos Pharma, Ltd. In total, 3 filings cover trades dated from 20 November 2024 to 8 October 2025.

Every open-market trade on record is a purchase: 1 purchase worth €5,430, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants.

The newest entry dates from 26 November 2025: a share grant, in Kairos Pharma, Ltd. The latest purchase dates back some time: it was published 696 days ago, on 21 November 2024. Typically, a trade is published a median of 49 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.